Literature DB >> 25625533

Screening for depression in epilepsy: a model of an enhanced screening tool.

Mihael Drinovac1, Helga Wagner1, Niruj Agrawal2, Hannah R Cock3, Alex J Mitchell4, Tim J von Oertzen5.   

Abstract

OBJECTIVE: Depression is common but frequently underdiagnosed in people with epilepsy. Screening tools help to identify depression in an outpatient setting. We have published validation of the NDDI-E and Emotional Thermometers (ET) as screening tools for depression (Rampling et al., 2012). In the current study, we describe a model of an optimized screening tool with higher accuracy.
METHODS: Data from 250 consecutive patients in a busy UK outpatient epilepsy clinic were prospectively collected. Logistic regression models and recursive partitioning techniques (classification trees, random forests) were applied to identify an optimal subset from 13 items (NDDI-E and ET) and provide a framework for the prediction of class membership probabilities for the DSM-IV-based depression classification.
RESULTS: Both logistic regression models and classification trees (random forests) suggested the same choice of items for classification (NDDI-E item 4, NDDI-E item 5, ET-Distress, ET-Anxiety, ET-Depression). The most useful regression model includes all 5 mentioned variables and outperforms the NDDI-E as well as the ET with respect to AUC (NDDI-E: 0.903; ET7: 0.889; logistic regression: 0.943). A model developed using random forests, grown by restricting the possible splitting of variables to these 5 items using only subsets of the original data for single classification, performed similarly (AUC: 0.949).
CONCLUSIONS: For the first time, we have created a model of a screening tool for depression containing both verbal and visual analog scales, with characteristics supporting that this will be more precise than previous tools. Collection of a new data sample to assess out-of-sample performance is necessary for confirmation of the predictive performance.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Comorbidity; Depression; Epilepsy; Human; Questionnaire; Screening

Mesh:

Year:  2015        PMID: 25625533     DOI: 10.1016/j.yebeh.2014.12.014

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  3 in total

1.  Innovative Identification of Substance Use Predictors: Machine Learning in a National Sample of Mexican Children.

Authors:  Alejandro L Vázquez; Melanie M Domenech Rodríguez; Tyson S Barrett; Sarah Schwartz; Nancy G Amador Buenabad; Marycarmen N Bustos Gamiño; María de Lourdes Gutiérrez López; Jorge A Villatoro Velázquez
Journal:  Prev Sci       Date:  2020-02

2.  Systemic Family Therapy of Comorbidity of Anxiety and Depression with Epilepsy in Adolescents.

Authors:  Jing Li; Xuefeng Wang; Huaqing Meng; Kebin Zeng; Fengying Quan; Fang Liu
Journal:  Psychiatry Investig       Date:  2016-05-18       Impact factor: 2.505

3.  A Proline Derivative-Enriched Fraction from Sideroxylon obtusifolium Protects the Hippocampus from Intracerebroventricular Pilocarpine-Induced Injury Associated with Status Epilepticus in Mice.

Authors:  Pedro Everson Alexandre de Aquino; Jéssica Rabelo Bezerra; Tyciane de Souza Nascimento; Juliete Tavares; Ítalo Rosal Lustosa; Adriano José Maia Chaves Filho; Melina Mottin; Danielle Macêdo Gaspar; Geanne Matos de Andrade; Kelly Rose Tavares Neves; Giuseppe Biagini; Edilberto Rocha Silveira; Glauce Socorro de Barros Viana
Journal:  Int J Mol Sci       Date:  2020-06-11       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.